These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 32789442)
1. Influence of Tumor Number on Clinicopathologic Features and Outcomes of Patients With Papillary Thyroid Carcinoma. Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Jiang Y; Ye J Am J Clin Pathol; 2020 Nov; 154(6):848-858. PubMed ID: 32789442 [TBL] [Abstract][Full Text] [Related]
2. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
3. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma. Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082 [TBL] [Abstract][Full Text] [Related]
4. Impact of thyroid carcinoma invasion of recurrent laryngeal nerve on cervical lymph node metastasis. Zhu F; Shen Y; Zhu L; Chen L; Li F; Xie X; Wu Y Endocrine; 2024 Nov; 86(2):654-663. PubMed ID: 38767775 [TBL] [Abstract][Full Text] [Related]
5. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma. Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178 [TBL] [Abstract][Full Text] [Related]
6. Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients. Ruan J; Chen Z; Chen S; Xu Z; Wen L; Mao Z; Shen J; Liu J; Wang W Endocrine; 2024 Feb; 83(2):414-421. PubMed ID: 37596455 [TBL] [Abstract][Full Text] [Related]
7. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma. Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713 [TBL] [Abstract][Full Text] [Related]
8. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence. Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354 [TBL] [Abstract][Full Text] [Related]
9. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification. Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416 [TBL] [Abstract][Full Text] [Related]
10. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer. Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781 [TBL] [Abstract][Full Text] [Related]
11. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis. Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997 [TBL] [Abstract][Full Text] [Related]
12. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422 [TBL] [Abstract][Full Text] [Related]
13. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer? Elbasan O; Ilgın C; Gogas Yavuz D Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491 [TBL] [Abstract][Full Text] [Related]
14. Number of tumor foci predicts prognosis in papillary thyroid cancer. Qu N; Zhang L; Ji QH; Zhu YX; Wang ZY; Shen Q; Wang Y; Li DS BMC Cancer; 2014 Dec; 14():914. PubMed ID: 25471041 [TBL] [Abstract][Full Text] [Related]
15. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls. Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297 [TBL] [Abstract][Full Text] [Related]
16. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis. Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303 [TBL] [Abstract][Full Text] [Related]
18. Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients. Song RY; Kim HS; Kang KH World J Surg Oncol; 2022 May; 20(1):170. PubMed ID: 35643530 [TBL] [Abstract][Full Text] [Related]
19. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma. Feng JW; Ye J; Wu WX; Pan H; Qin AC; Jiang Y; Wu BQ Front Endocrinol (Lausanne); 2020; 11():553577. PubMed ID: 33133013 [TBL] [Abstract][Full Text] [Related]
20. Predictive value of the Delphian lymph node in cervical lymph node metastasis of papillary thyroid carcinoma. Yan Y; Wang Y; Liu N; Duan Y; Chen X; Ye B; Yang R; Zhang W; Wang X Eur J Surg Oncol; 2021 Jul; 47(7):1727-1733. PubMed ID: 33632590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]